Hedge Fund News: Louis Bacon, Chase Coleman & Third Point
The hedge fund billionaire Louis M.
Posts Tagged ‘Allergan Inc (AGN)’
Allergan Inc. (AGN), Anadarko Petroleum Corporation (APC), DISH Network Corp (DISH): Thomas A. Giovine Loves These Stocks
As the 13F season continues, let’s take a look at Giovine Capital’s recently disclosed long equity positions for the second quarter of 2014.
Valeant Pharmaceuticals Intl Inc (VRX), Bill Ackman on Radars Over Allergan, Inc. (AGN) Insider Trading Scandal
Billionaire investor and hedge fund Manager Bill Ackman of Pershing Square has been in the news recently for all the wrong reasons. Allergan, Inc.
Hedge Fund News: Carl Icahn, Bill Ackman & Marcato Capital Management
Carl Icahn makes more money between sips on his outsized Martinis than most mortals make in a lifetime.
Earnings Snapshot: Six Flags Entertainment Corp (SIX), Allergan, Inc. (AGN) and Petmed Express Inc (PETS)
Six Flags Entertainment Corp (NYSE:SIX), the world’s largest regional theme park company, reported second quarter revenues of $376.55 million, up from last year’s second...
Hedge Fund News: Eric Mindich, Warren Lichtenstein & Daniel Loeb
Investors have pulled more than $1 billion from Eric Mindich's Eton Park Fund, managed by his New York-based multistrategy hedge fund firm Eton Park Capital Management, since ...
Hedge Fund News: Stanley Druckenmiller, John Paulson & Starboard Value LP
The Fed is out of step with Wall Street, say some of the country’s wealthiest investors.
Deepak Gulati’s Argentiere Capital’s Top Stock Picks
Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr.
Hedge Fund News: Jim Simons, Feroz Dewan & Soros Fund Management
Long Island hedge-fund investor James Simons and his wife have given $50 million to the Cold Spring Harbor Laboratory to establish a center that uses quantitative tools to understand...
Bill Ackman’s Pershing Square Settles Litigation With Allergan Inc. (AGN)
Pershing Square, managed by Bill Ackman, revealed in a new filing with the U.S. Securities and Exchange Commission that it has settled a lawsuit with Allergan Inc. (NYSE:AGN).
North Tide Capital’s Healthcare Stock Picks
North Tide Capital financial investment advisory firm headquartered in Boston, Massachusetts, founded and managed by Conan Laughlin. Before this, Mr.
Hedge Fund News: Daniel Loeb, Bill Ackman & Tiger Global Management
Third Point LLC, a hedge fund controlled by activist investor Daniel Loeb, has bought more than 1 million shares of the common stock of Roper Industries, Inc. (NYSE:ROP).
Hedge Fund News: Ken Griffin, David Einhorn & Bill Ackman
The asset management industry is playing US regulators against their international counterparts and stirring national sentiment on Capitol Hill in an attempt to head off new regulation...
Hedge Fund News: Jim Chanos, Thomas Steyer & Carl Icahn
Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.
Hedge Fund News: Bill Ackman, Crispin Odey & David Tepper
Canada’s largest pharmaceutical company and the U.S. activist investor who overhauled CP Rail have joined forces in a mega-deal to buy Allergan, Inc.
Pershing Square Forms Joint Entity with Valeant Pharmaceuticals International Inc (VRX) to Acquire Allergan, Inc. (AGN)
Bill Ackman's Pershing Square has added Allergan, Inc. (NYSE:AGN) to its equity portfolio.
Nehal Chopra’s Ratan Capital is Betting on These Stocks
Nehal Chopra is a graduate from the Wharton School of the University of Pennsylvania.
Visium Asset Management Adds NephroGenex Inc (NRX) and Ignyta Inc (RXDX) to its Equity Portfolio
Visium Asset Management, led by Jacob Gottlieb, has added NephroGenex Inc (NASDAQ:NRX) and Ignyta Inc (OTCBB:RXDX) to its equity portfolio.
Akorn, Inc. (AKRX), Hi-Tech Pharmacal Co. (HITK): The New Leader in Ophthalmology
This space has a bright future outlook, and according to Markets and Markets, it is projected to reach a market size of $36 billion by 2014, increasing at a CAGR of 5.4% during...
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Allergan, Inc. (AGN), Sanofi SA (ADR) (SNY): New FDA Guidelines Hit This Company Hard
Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.
Allergan, Inc. (AGN): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Forest Laboratories, Inc. (FRX): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost to time.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Allergan, Inc. (AGN): Three Companies Working to Make Your Migraines Milder
The National Headache Foundation (yes, there is such an organization) says that around 30 million Americans suffer from migraines.
Will Regeneron Pharmaceuticals Inc (REGN) Earnings Grow Fast Enough for Investors?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will release its quarterly report on Tuesday, and the company's stock has been on an absolute tear over the past year.
Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK) – Hold On to Your Hair: Three Leading Treatments for Male Pattern Baldness
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Allergan, Inc. (AGN): A New Migraine Therapy That Can Address a Major Demand
One-fourth of all migraine patients suffer nasty side effects from the market's dominant migraine-fighting treatments.
Spectrum Pharmaceuticals, Inc. (SPPI): Is This Biotech for Sale?
For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc.
The Dow Chemical Company (DOW), Allergan, Inc. (AGN), Barrick Gold Corporation (USA) (ABX): Three Stocks To Short
After a strong bull run in 2013, it appears that the markets are set to reverse and enter bear territory.
Chipotle Mexican Grill, Inc. (CMG), Allergan, Inc. (AGN), Verisign, Inc. (VRSN): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
For Allergan, Inc. (AGN) Shareholders, Will it Be Dry Eyes or Tears of Joy?
On June 24, the Food and Drug Administration issued “bioequivalence recommendations” for 15 active ingredients used in prescription medications.
Johnson & Johnson (JNJ): New Drugs and Better Manufacturing Make This Stock a Buy
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Allergan, Inc. (AGN), Cliffs Natural Resources Inc (CLF), Peabody Energy Corporation (BTU): Today’s Three Worst Stocks
Last week, Wall Street couldn't think about anything other than the specter of Fed tapering. This week, it's found a new central bank to disapprove of.
Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK): The Top 3 Medical Uses of Botox
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
ACADIA Pharmaceuticals Inc. (ACAD): What’s Next For This Biotech?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’ 1,100% gain makes it one of the best performing stocks in the market.
ACADIA Pharmaceuticals Inc. (ACAD) Soars On Hedge Fund Investment
One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are doing.
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Three Humongous Health-Care Stocks This Week
Summer doesn't officially arrive for a few more weeks, but the first week of June packed some real heat.
Citrix Systems, Inc. (CTXS), Allergan, Inc. (AGN): What I Bought and Sold This Quarter
In the end, numbers are just numbers and while they are an indispensable part of an investor's self-assessment, they do not always reveal the full details.
Three Keys to ACADIA Pharmaceuticals Inc. (ACAD)’s Future
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had a busy couple of months.
Valeant Pharmaceuticals Intl Inc (VRX) is Expanding its Eye Care Business
The pharmaceutical industry is getting hotter with increasing M&A activities.
Allergan, Inc. (AGN), Novo Nordisk A/S (ADR) (NVO): Should These Drug Companies Continue to Pay a Dividend?
Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend.
Do Hedge Funds and Insiders Love Allergan, Inc. (AGN)?
Allergan, Inc. (NYSE:AGN) was in 31 hedge funds' portfolio at the end of the first quarter of 2013. AGN has seen a decrease in hedge fund interest in recent months.
Allergan, Inc. (AGN), Dr. Reddy’s Laboratories Limited (ADR) (RDY): Should These Drug Companies Pay a Dividend?
Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend.
Allergan, Inc. (AGN): Is It Worth Looking At?
Allergan, Inc. (NYSE:AGN) has been consistently increasing on the market since the market bottom, from nearly $32 per share in November 2008 to more than $116 per share in ...
Merck & Co., Inc. (MRK), AVEO Pharmaceuticals, Inc. (AVEO): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Allergan, Inc. (AGN), Regeneron Pharmaceuticals Inc (REGN), And What You Should Know
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Allergan, Inc. (AGN): This Stock Waits to Exhale
Allergan, Inc. (NYSE:AGN) announced today that the Food and Drug Administration issued a complete response letter for Levadex, an inhalable drug that treats migraines.
Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK), and Three ‘Cannot Miss’ FDA Actions This Week
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration...
Alcoa Inc (AA), F5 Networks, Inc. (FFIV) & More: Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
